MS Research Spotlight: NfL Biomarker, Dysphagia & More
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MultipleSclerosis.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Siotto M, Filippi MM, Simonelli I, et al. Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability. Frontiers in Neuroscience. 2019;13. doi:10.3389/fnins.2019.00086.
- Jens Kuhle, Harald Kropshofer, Dieter A. Haering, Uma Kundu, Rolf Meinert, Christian Barro, Frank Dahlke, Davorka Tomic, David Leppert, Ludwig Kappos. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. Feb 2019, 10.1212/WNL.0000000000007032; DOI:10.1212/WNL.0000000000007032
- Tarameshlu, Maryam et al. The effect of traditional dysphagia therapy on the swallowing function in patients with Multiple Sclerosis: A pilot double-blinded randomized controlled trial. Journal of Bodywork and Movement Therapies , Volume 23 , Issue 1 , 171 – 176. January 2019.
- Kasser SL, Jacobs JV, Sibold J, Marcus A, Cole L. Employing Body-Worn Sensors to Detect Changes in Balance and Mobility After Acute Aerobic Exercise in Adults with Multiple Sclerosis. International Journal of MS Care. 2019. doi:10.7224/1537-2073.2018-073.